The trend toward faster, simpler closure techniques is being driven in large part by strides in the processing of proteins possessing natural adhesion properties. “Biological sealants based on natural adhesion promoters such as fibrin, platelet gels, modified collagen, and recombinant proteins are gaining market share on synthetic sealants,” explains George Perros, Greystone’s Managing Director. “These advanced closure and sealing products and techniques save time, which equates to saving money.” Other emerging wound closure techniques include energy methods based on ultrasound and radio frequency.
These findings are contained in a new and comprehensive report: Advanced Wound Closure: Innovative Technology, Emerging Opportunities. The report contains a detailed assessment of advanced wound closure technology and products, profiles of market participants, industry data and forecasts, and detailed analysis of regulatory and market factors. Organized and written to be of maximum value to medical market professionals, technology providers, and market segment stakeholders, the report provides a detailed assessment of the growing potential for new and emerging wound closure technology.
More information is available at www.greystoneassociates.org .
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
Source: Greystone Associates
For more information:
Last updated on: 27/08/2010
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.